Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Bradbury

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Disaster Medicine and Public Health Preparedness|September 16, 2025
A Curve-Fitting Approach for Generating Long-Term Projections of COVID-19 MortalityGeorge Kafatos, George Seegan, Bagmeet Behera, et al.
American Journal of Nephrology|September 30, 2009
Hemoglobin level variability: anemia management among variability groupsDavid T Gilbertson, Yi Peng, Brian Bradbury, et al.
Therapeutic Innovation & Regulatory Science|October 11, 2021
A Novel Case Study of the Use of Real-World Evidence to Support the Registration of an Osteoporosis Product in ChinaNeal E Storm, Wen Chang, Tzu-Chieh Lin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2010
Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational studyStephen Seliger, Kathleen M Fox, Shravanthi R Gandra, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Disaster Medicine and Public Health Preparedness|September 16, 2025
A Curve-Fitting Approach for Generating Long-Term Projections of COVID-19 MortalityGeorge Kafatos, George Seegan, Bagmeet Behera, et al.
American Journal of Nephrology|September 30, 2009
Hemoglobin level variability: anemia management among variability groupsDavid T Gilbertson, Yi Peng, Brian Bradbury, et al.
Therapeutic Innovation & Regulatory Science|October 11, 2021
A Novel Case Study of the Use of Real-World Evidence to Support the Registration of an Osteoporosis Product in ChinaNeal E Storm, Wen Chang, Tzu-Chieh Lin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2010
Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational studyStephen Seliger, Kathleen M Fox, Shravanthi R Gandra, et al.
Pageof 1